MAP4K4 and hepatocellular carcinoma: Overexpression of MAP4K4 was identified as a prognostic indicator in multiple cancers, including hepatocellular carcinoma (HCC), PDAC, lung cancer, colorectal cancer (CRC) and prostate cancer [17–21].